A Novel LINC00478/ LINC01549 Intergenic Region -ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma

JTO Clin Res Rep. 2020 Oct 17;2(1):100112. doi: 10.1016/j.jtocrr.2020.100112. eCollection 2021 Jan.

Authors

Wei Peng¹, Si Li², Lijian Li², Mingzhe Xiao², Jincai Zhong¹

Affiliations

¹ Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
² The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co. Ltd., Nanjing, People's Republic of China.

No abstract available

Publication types

Case Reports